Nathan Haas

Part of Vitro Biopharma, Inc., Fitore, Inc. is a company that combines the best of nature and science to create superior health and nutrition supplements. Fitore is based in Denver, CO and was founded in 2019 by Tanner Haas and Nathan Haas. The company carefully selects all of its ingredients and works with world-class doctors to ensure the highest quality products. Tanner Haas has been the CEO since 2019. Fitore was acquired by Vitro Biopharma, Inc. on August 31, 2021 for $2.30 million.

Vitro Biopharma, Inc. develops and commercializes adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. Its products include cell culture media, cell lines, and nutravivo-dietary-supplements. The company was founded by James R. Musick on March 31, 1986 and is headquartered in Denver, CO.

Part of Vitro Biopharma, Inc., Infinivive MD LLC is a company that has created a high-quality cosmetic stem cell and exosomes product line. The company is based in Denver, CO. Infinivive MD cosmetic stem cell products contain ultra-pure mesenchymal stem cells and exosomes to be used topically by plastic surgeons, cosmetic surgeons, and aestheticians throughout and internationally. The company aims to disrupt the cosmetic industry through next-level skin quality results, with products designed to moisturize and hydrate the skin and reduce the appearance of fine lines and wrinkles, developed from proprietary stem cell technology to help promote natural healing. The company was founded in 2018 by Jack Zamora. Infinivive MD was acquired by Vitro Biopharma, Inc. on August 31, 2021 for $5.75 million.

BrightEdge LLC is a venture capital fund that invests in early-stage companies developing cancer-focused therapeutics, diagnostics, devices, and technologies to bring innovative solutions to market. The company's mission is to accelerate the American Cancer Society's goal to reduce cancer mortality, end pain and suffering, and advance health equity. BrightEdge has received a $1.25 million grant from the WoodNext Foundation to launch an entrepreneurship fellows program to support and fund scientific founders and their early-stage companies among American Cancer Society-affiliated postdoctoral and early career researchers. The non-profit company is led by a world-class team of investors, operators, and entrepreneurs who are fighting for a world without cancer.